http://www.surepulsemedical.com/

Sure Pulse Medical, Medicity, D6 Thane Road, Nottingham (2026)

04/03/2026

Dr Anne Maire Heuchan, Consultant Neonatologist at Glasgow Children’s Hospital discusses the challenges of monitoring heart rate at birth.

Find out more about our wireless heart rate monitoring solutions for the delivery room: https://buff.ly/0hBds9J

02/03/2026

We’re looking forward to attending the 17th Dresden Symposium
🗓 March 12–13, 2026
📍 Dresden, Germany

The symposium is a key platform for intensive discussion around Delivery Room Management and the latest developments in neonatology, bringing together clinicians and companies dedicated to improving newborn care.

We’re excited to be there in person and engage with peers committed to advancing care at birth.

26/02/2026

Researchers in California have published a study reporting that that deferred cord clamping (DCC) for at least 30 seconds is associated with a modest but statistically significant increase in first-recorded weight among very preterm infants (

23/02/2026

Did you know that 10% of newborns—that’s 380,000 babies each year in the U.S.—require stabilization after birth?

Failure to keep newborns within safe vital sign parameters can have serious consequences. For example, if a baby’s heart rate stays below 100 bpm for just 2 minutes, the risk of death increases 5-fold. (Kapadia)

That’s why we developed SurePulse VS—a wireless heart rate monitoring Cap that delivers quick, accurate, real-time data when every second matters.

Because timely intervention saves lives.

18/02/2026

Optimal cord clamping (OCC) offers vital benefits for newborns; improved oxygenation, higher iron stores, and better cardiovascular stability. Yet, in critical moments, ensuring a baby’s well-being while keeping the cord intact can be challenging. Traditional monitoring methods often require clamping and cutting the cord early to assess vital signs quickly.

What if we could do both?

With SurePulse wireless vital sign monitoring, we can provide provide clinical teams with accurate, reliable, and timely information in the critical moments after birth. This means:

✅ Real-time vital sign monitoring while the cord remains intact
✅ Supporting clinical decision-making without premature cord clamping

Read our article on the latest Optimal Cord Clamping Guidelines https://buff.ly/3XgHO8M

16/02/2026

Last year we shared the findings of an independent review by the UK Department of Health & Social Care which highlighted concerns about racial bias in medical devices, particularly in pulse oximeters. Research shows that these devices overestimate oxygen levels in patients with darker skin tones, potentially delaying critical care.

In neonatal care, accurate monitoring is vital. That’s why SurePulse VS stands out. Designed to provide precise and reliable heart rate monitoring for newborns, regardless of skin tone. This innovation ensures equitable and optimal care for all babies from birth.

📖 Read more here: https://buff.ly/40WqEzB

11/02/2026

The Impact of Admission Temperature on Very Preterm Infants.

A nationwide study in Norway has confirmed that lower admission temperatures in very preterm infants significantly increase mortality and morbidity risks. Implementing standardized temperature-preserving measures and continuous monitoring could enhance neonatal care and reduce risks for vulnerable preterm infants.

SurePulse is pioneering continuous temperature monitoring, developing a wireless solution to enhance newborn stabilisation. Early research show its potential to outperform traditional methods.

🔗 Read more & explore the research: https://buff.ly/ilvMVdE

09/02/2026

A UK real world evaluation of SurePulse VS was presented at the jENS Neonatal congress in Rome (September 2023). The authors concluded:

‘‘This relatively new HR monitoring approach demonstrated feasibility for use in preterm babies in our tertiary-level centre, and good staff user acceptability. Wireless HR monitoring has the potential for assisting safe and effective monitoring by staff, while allowing parents greater autonomy during first cuddles with their babies in the DR, and during skin-to-skin/kangaroo care in the NICU’’.

Read more about the publication here: https://zurl.co/XoXe

05/02/2026

The American Heart Association (AHA) and American Academy of Pediatrics (AAP) guidelines for Neonatal Life Support were updated at the end of last year.

➡️ The guidelines continue to emphasis the critical role of heart rate monitoring as the key marker for assessing a newborn’s response to resuscitation. 'A rise in heart rate is the primary indicator of effective ventilation.'

➡️ The 2025 guidelines also highlight the importance of continuous temperature monitoring during resuscitation to prevent hypothermia and hyperthermia, both linked to adverse outcomes.

➡️ Skin-to-skin contact is encouraged “whenever possible,” with close monitoring of breathing and temperature for at least 1 hour to support early breastfeeding.

Read the full article for the key updates ➡️ https://buff.ly/EIaNZxf

03/02/2026

Applying ECG electrodes to newborns with vernix-covered skin can be challenging, often leading to dislodgement and potential skin injuries (Mizumoto, 2012). A study by Henry et al. (2022) explored a novel ECG electrode placement method using a patch secured through surface tension. Their findings? The new method was three times faster to apply than traditional individual electrodes.

Learn more about this innovative approach here: https://buff.ly/3CIwZFy

28/01/2026

Dr Anne Maire Heuchan, Consultant Neonatologist at Glasgow Children’s Hospital discusses the challenges of monitoring heart rate at birth.

Find out more about our wireless heart rate monitoring solutions for the delivery room: https://buff.ly/OPtrJ13

26/01/2026

Measuring heart rate is crucial for critically unwell newborn infants, but traditional limb-based pulse oximeters can struggle when blood flow shifts to vital organs. As a forehead-based PPG sensor, the SurePulse VS offers a promising alternative!

A study comparing forehead vs. wrist sensors in 19 NICU infants (198 hours of data) found strong agreement between the two, with:
✅ 98.87% positive percentage agreement
✅ High correlation (Spearman’s 0.9816)
✅ Reliable accuracy for vital sign monitoring

The SurePulse VS has the potential to be a significant advancement in the way neonatal patients are monitored. Read the full study here: https://buff.ly/gpR4Q7B

Sure Pulse Medical

04/03/2026

02/03/2026

26/02/2026

23/02/2026

18/02/2026

16/02/2026

11/02/2026

09/02/2026

05/02/2026

03/02/2026

28/01/2026

26/01/2026

Address

Website

Alerts

Shortcuts

Share

Category